CVE-2022-36051
ZITADEL combines the ease of Auth0 and the versatility of Keycloak.**Actions**, introduced in ZITADEL **1.42.0** on the API and **1.56.0** for Console, is a feature, where users with role.`ORG_OWNER` are able to create Javascript Code, which is invoked…
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (0.97%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
ZITADEL combines the ease of Auth0 and the versatility of Keycloak.**Actions**, introduced in ZITADEL **1.42.0** on the API and **1.56.0** for Console, is a feature, where users with role.`ORG_OWNER` are able to create Javascript Code, which is invoked by the system at certain points during the login. **Actions**, for example, allow creating authorizations (user grants) on newly created users programmatically. Due to a missing authorization check, **Actions** were able to grant authorizations for projects that belong to other organizations inside the same Instance. Granting authorizations via API and Console is not affected by this vulnerability. There is currently no known workaround, users should update.
- CVSS 3.1
- 8.8 HIGHCVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 0.97% probability · 60th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-436, CWE-863
- Affected
- zitadel/zitadel
- Source
- security-advisories@github.com
References
- https://github.com/zitadel/zitadel/releases/tag/v1.87.1Third Party Advisory
- https://github.com/zitadel/zitadel/releases/tag/v2.2.0Patch, Release Notes, Third Party Advisory
- https://github.com/zitadel/zitadel/security/advisories/GHSA-c8fj-4pm8-mp2cThird Party Advisory
- https://github.com/zitadel/zitadel/releases/tag/v1.87.1Third Party Advisory
- https://github.com/zitadel/zitadel/releases/tag/v2.2.0Patch, Release Notes, Third Party Advisory
- https://github.com/zitadel/zitadel/security/advisories/GHSA-c8fj-4pm8-mp2cThird Party Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.